Assignee
ALTOR BIOSCIENCE CORP
US·16 granted patents·10 pending applications·513 citations·filing 1999–2019
Top patents by PatentIndex Score
26 records- 0199US10150805B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Dec 11, 2018·44 cites·20 claims
- 0298US10450359B2IL-15 variants and uses thereofALTOR BIOSCIENCE CORP·Filed 2016·Granted Oct 22, 2019·29 cites·14 claims
- 0398US10358478B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Jul 23, 2019·26 cites·18 claims
- 0498US9925247B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2015·Granted Mar 27, 2018·37 cites·25 claims
- 0598US9464127B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE CORP·Filed 2013·Granted Oct 11, 2016·49 cites·21 claims
- 0698US9428573B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted Aug 30, 2016·56 cites·32 claims
- 0798US9328159B2Multimeric IL-15 soluble fusion molecules and methods of using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted May 3, 2016·54 cites·9 claims
- 0897US10865230B2Construction and characterization of multimeric IL-15-based molecules with CD3 binding domainsALTOR BIOSCIENCE CORP·Filed 2017·Granted Dec 15, 2020·21 cites·15 claims
- 0996US9593152B2Methods of treating disease with fusion molecules comprising IL-15 variantsALTOR BIOSCIENCE CORP·Filed 2014·Granted Mar 14, 2017·23 cites·5 claims
- 1090US7141656B2MHC complexes and uses thereofALTOR BIOSCIENCE CORP·Filed 2001·Granted Nov 28, 2006·32 cites·28 claims
- 1189US7456263B2P53 binding T cell receptor moleculesALTOR BIOSCIENCE CORP·Filed 2002·Granted Nov 25, 2008·37 cites·23 claims
- 1286US7074904B2MHC complexes and uses thereofALTOR BIOSCIENCE CORP·Filed 2001·Granted Jul 11, 2006·34 cites·10 claims
- 1386US6534633B1Polyspecific binding molecules and uses thereofALTOR BIOSCIENCE CORP·Filed 1999·Granted Mar 18, 2003·53 cites·31 claims
- 1483US7074905B2Soluble MHC complexes and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2001·Granted Jul 11, 2006·17 cites·19 claims
- 1573US9714279B2HIV vpr-specific T-cell receptorsALTOR BIOSCIENCE CORP·Filed 2014·Granted Jul 25, 2017·1 cites·26 claims
- 1669US2020172594A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2019·Application pending·0 cites
- 1766US2015079025A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2014·Application pending·0 cites
- 1866US2019269807A1Soluble tcr molecules and methods of useALTOR BIOSCIENCE CORP·Filed 2019·Application pending·0 cites
- 1959US9290560B2Soluble TCR molecules and methods of useALTOR BIOSCIENCE CORP·Filed 2014·Granted Mar 22, 2016·0 cites·10 claims
- 2058US2018200366A1Multimeric il-15-based moleculesALTOR BIOSCIENCE CORP·Filed 2017·Application pending·0 cites
- 2156US2016199523A1Soluble tcr molecules and methods of useALTOR BIOSCIENCE CORP·Filed 2016·Application pending·0 cites
- 2252US2018086810A1T cell receptor fusions and conjugates and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2017·Application pending·0 cites
- 2347US2015216937A1Methods for treating neoplasiaALTOR BIOSCIENCE CORP·Filed 2013·Application pending·0 cites
- 2446US2007116718A1Fusion proteins comprising bacteriophage coat protein and asingle-chain T cell receptorALTOR BIOSCIENCE CORP·Filed 2006·Application pending·0 cites
- 2539US2017088597A1Interleukin-15 superagonist significantly enhances graft-versus-tumor activityALTOR BIOSCIENCE CORP·Filed 2016·Application pending·0 cites
- 2638US2019048055A1Alt-803 in combination with anti-cd38 antibody for cancer therapiesALTOR BIOSCIENCE CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALTOR BIOSCIENCE CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →